Bruce A. Leicher
Presidente en Biosimilars Council .
Cargos activos de Bruce A. Leicher
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Foundation for Biomedical Research
 Foundation for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Foundation for Biomedical Research provides animal research and testing services. The non-profit company is based in Washington. | Corporate Officer/Principal | - | - |
Biosimilars Council
 Biosimilars Council Miscellaneous Commercial ServicesCommercial Services Biosimilars Council is a division of the Association for Accessible Medicines. The private company is based in Washington. The American company works towards ensuring a positive future for biosimilar medicines. | Presidente | - | - |
Historial de carrera de Bruce A. Leicher
Antiguos cargos conocidos de Bruce A. Leicher.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Consejero General | 24/07/2008 | 05/10/2018 |
| Secretario Corporativo | 25/07/2009 | 05/10/2018 | |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Consejero General | 01/07/2008 | 01/07/2008 |
| Secretario Corporativo | 01/07/2008 | 01/07/2008 | |
| AGENUS INC. | Consejero General | 01/12/2006 | 01/12/2006 |
| Secretario Corporativo | 01/12/2006 | 01/12/2006 | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/11/2005 | 01/11/2005 |
| Hill & Barlow, Inc. | Corporate Officer/Principal | 01/12/2002 | 01/12/2002 |
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | Consejero General | 01/12/2000 | 01/12/2000 |
| Secretario Corporativo | 01/12/2000 | 01/12/2000 | |
| CURIS, INC. | Consejero General | 01/12/2000 | 01/12/2000 |
| Secretario Corporativo | 01/12/2000 | 01/12/2000 | |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | - | - |
Formación de Bruce A. Leicher.
| Rochester Christian University | Undergraduate Degree |
| Georgetown University Law Center | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 17 |
Operativa
| General Counsel | 10 |
| Corporate Secretary | 7 |
| Corporate Officer/Principal | 3 |
Sectorial
| Health Technology | 12 |
| Commercial Services | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| AGENUS INC. | Health Technology |
| CURIS, INC. | Health Technology |
| ANTIGENICS, INC. | Health Technology |
| Empresas privadas | 11 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
| Hill & Barlow, Inc. | Commercial Services |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | Health Technology |
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Health Technology |
Reprogenesis, Inc.
 Reprogenesis, Inc. BiotechnologyHealth Technology Reprogenesis, Inc., located in Cambridge, Massachusetts developes tissue engineered therapies to treat unmet medical needs. The Company has proprietary technology utilizing the combination of cells and biomaterials to restore, repair or replace lost tissue or physiological function. The Company has a broad preclinical and clinical pipeline of products in the areas of urology, cardiovascular biology and plastic and reconstructive surgery. ChondrogelTM is its most advanced product | Health Technology |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Foundation for Biomedical Research
Foundation for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Foundation for Biomedical Research provides animal research and testing services. The non-profit company is based in Washington. | Commercial Services |
Biosimilars Council
Biosimilars Council Miscellaneous Commercial ServicesCommercial Services Biosimilars Council is a division of the Association for Accessible Medicines. The private company is based in Washington. The American company works towards ensuring a positive future for biosimilar medicines. | Commercial Services |
- Bolsa de valores
- Insiders
- Bruce A. Leicher
- Experiencia
